1
Trivalent Influenza Vaccine in Preventing Flu in Patients With Central Nervous System Tumors
Condition(s):Central Nervous System NeoplasmLast Updated:July 3, 2018Completed
Central Nervous System: 42420 Clinical Trials, Page 1 of 4242
Hide Studies Not Open or Pending
2
Rituximab, Lenalidomide Combined With Methotrexate and Temozolomide For Primary Central Nervous System Lymphoma
Condition(s):Primary Central Nervous System LymphomaLast Updated:February 4, 2021Recruiting
3
Ketogenic Diet Adjunctive to HD-MTX Chemotherapy for Primary Central Nervous System Lymphoma
Condition(s):Primary Central Nervous System LymphomaLast Updated:December 6, 2016Unknown status
4
Study of B7-H3-Specific CAR T Cell Locoregional Immunotherapy for Diffuse Intrinsic Pontine Glioma/Diffuse Midline Glioma and Recurrent or Refractory Pediatric Central Nervous System Tumors
Condition(s):Central Nervous System Tumor; Diffuse Intrinsic Pontine Glioma; Diffuse Midline Glioma; Ependymoma; Medulloblastoma, Childhood; Germ Cell Tumor; Atypical Teratoid/Rhabdoid Tumor; Primitive Neuroectodermal Tumor; Choroid Plexus Carcinoma; Pineoblastoma, Childhood; GliomaLast Updated:March 15, 2021Recruiting
5
Early Systemic Central Nervous System Prophylaxis in Diffuse Large B-cell Lymphoma
Condition(s):Diffuse Large B Cell LymphomaLast Updated:April 13, 2020Withdrawn
6
Molecular Prognosis of Lymphomas of the Central Nervous System (ALYCE-molecular)
Condition(s):Central Nervous System LymphomaLast Updated:March 1, 2019Unknown status
7
A Study the Population Pharmacokinetics of Children of Infectious Disease in Central Nervous System
Condition(s):Central Nervous System InfectionLast Updated:May 23, 2019Recruiting
8
Medical Marijuana in the Pediatric Central Nervous System Tumor Population
Condition(s):Central Nervous System Tumor; Brain Tumor; Spinal TumorLast Updated:March 22, 2021Recruiting
9
Fluorescence Detection of Adult Primary Central Nervous System Tumors With Tozuleristide and the Canvas System
Condition(s):Central Nervous System TumorLast Updated:February 8, 2021Not yet recruiting
10
PQR309 in Patients With Relapsed or Refractory Primary Central Nervous System Lymphoma
Condition(s):Primary Central Nervous System LymphomaLast Updated:July 9, 2019Completed